Your institution may have access to this item. Find your institution then sign in to continue.
Title
Natalizumab treatment during pregnancy - effects on the neonatal immune system.
Authors
Schneider, H; Weber, C E; Hellwig, K; Schroten, H; Tenenbaum, T
Abstract
Pregnancies in women with severe relapsing-remitting multiple sclerosis treated with natalizumab constitute a major challenge, because withdrawal of the drug may cause relapses but continuation might have unknown effects on the infantile immune system.